drugset / Trial / NCT01216943

Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension

NCT01216943

Phase 3 Completed 126 enrolled Allergan
NaSingle-groupOpen-labelTreatment

Summary

This study will investigate the safety and efficacy of Triple Combination Therapy (bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution) in patients with glaucoma or ocular hypertension who have elevated intraocular pressure (IOP) on brimonidine/timolol ophthalmic solution.

Timeline

Start
2010-11
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.01 % Other
Background Brimonidine Small molecule 0.15 % Other
Background Timolol Other / unclassified 0.5 % Other